PHARMACYTE BIOTECH, INC. Operating Loss Carryforwards
PHARMACYTE BIOTECH, INC. (PMCB) had Operating Loss Carryforwards of $64.68 million as of 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-07-29
- 2026-04-30: Operating Loss Carryforwards $64.68M.
- 2025-04-30: Operating Loss Carryforwards $35.75M; Operating Loss Carryforwards as first filed $61.27M.
- 2024-04-30: Operating Loss Carryforwards $57.38M.
- 2024-01-31: Operating Loss Carryforwards $58.02M.
| Period end | Operating Loss Carryforwards | Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-04-30 | $64.68M 10-K · filed 2026-07-29 | |
| 2025-04-30 | $35.75M 10-K · filed 2026-07-29 | $61.27M 10-K · filed 2025-08-11 |
| 2024-04-30 | $57.38M 10-K · filed 2024-08-13 | |
| 2024-01-31 | $58.02M 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $57.15M 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $58.70M 10-Q · filed 2023-09-18 | |
| 2023-01-31 | $55.94M 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $55.84M 10-Q · filed 2022-12-14 | |
| 2022-07-31 | $53.88M 10-Q · filed 2022-09-14 | |
| 2022-04-30 | $52.38M 10-K · filed 2022-07-28 | |
| 2021-08-31 | $40.84M 10-Q · filed 2022-12-14 | |
| 2021-04-30 | $47.90M 10-K · filed 2021-08-10 | |
| 2020-04-30 | $44.86M 10-K · filed 2020-08-13 | |
| 2019-04-30 | $42.40M 10-K · filed 2019-08-13 | |
| 2018-04-30 | $43.99M 10-K · filed 2019-08-13 | $39.45M 10-K · filed 2018-07-20 |
| 2017-04-30 | $39.45M 10-K · filed 2018-07-20 | $34.34M 10-K · filed 2017-07-27 |
| 2016-04-30 | $34.34M 10-K · filed 2017-07-27 | $36.17M 10-K · filed 2016-07-29 |
| 2015-04-30 | $36.17M 10-K · filed 2016-07-29 | $33.26M 10-K · filed 2015-07-29 |
| 2014-04-30 | $33.26M 10-K/A · filed 2016-01-19 | -$37.71M 10-K · filed 2014-08-04 |
| 2013-04-30 | -$36.64M 10-K · filed 2014-08-04 | $1.60M 10-K · filed 2013-07-29 |
| 2012-04-30 | $1.90M 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |